353 related articles for article (PubMed ID: 31292158)
1. Oncogenic MYC Induces the Impaired Ribosome Biogenesis Checkpoint and Stabilizes p53 Independent of Increased Ribosome Content.
Morcelle C; Menoyo S; Morón-Duran FD; Tauler A; Kozma SC; Thomas G; Gentilella A
Cancer Res; 2019 Sep; 79(17):4348-4359. PubMed ID: 31292158
[TBL] [Abstract][Full Text] [Related]
2. 5S ribosomal RNA is an essential component of a nascent ribosomal precursor complex that regulates the Hdm2-p53 checkpoint.
Donati G; Peddigari S; Mercer CA; Thomas G
Cell Rep; 2013 Jul; 4(1):87-98. PubMed ID: 23831031
[TBL] [Abstract][Full Text] [Related]
3. Cancer-associated mutations in the ribosomal protein L5 gene dysregulate the HDM2/p53-mediated ribosome biogenesis checkpoint.
Oršolić I; Bursać S; Jurada D; Drmić Hofman I; Dembić Z; Bartek J; Mihalek I; Volarević S
Oncogene; 2020 Apr; 39(17):3443-3457. PubMed ID: 32108164
[TBL] [Abstract][Full Text] [Related]
4. Perturbation of RNA Polymerase I transcription machinery by ablation of HEATR1 triggers the RPL5/RPL11-MDM2-p53 ribosome biogenesis stress checkpoint pathway in human cells.
Turi Z; Senkyrikova M; Mistrik M; Bartek J; Moudry P
Cell Cycle; 2018; 17(1):92-101. PubMed ID: 29143558
[TBL] [Abstract][Full Text] [Related]
5. The pre-existing population of 5S rRNA effects p53 stabilization during ribosome biogenesis inhibition.
Onofrillo C; Galbiati A; Montanaro L; Derenzini M
Oncotarget; 2017 Jan; 8(3):4257-4267. PubMed ID: 28032591
[TBL] [Abstract][Full Text] [Related]
6. Activation of the tumor suppressor p53 upon impairment of ribosome biogenesis.
Bursac S; Brdovcak MC; Donati G; Volarevic S
Biochim Biophys Acta; 2014 Jun; 1842(6):817-30. PubMed ID: 24514102
[TBL] [Abstract][Full Text] [Related]
7. Disruption of the RP-MDM2-p53 pathway accelerates APC loss-induced colorectal tumorigenesis.
Liu S; Tackmann NR; Yang J; Zhang Y
Oncogene; 2017 Mar; 36(10):1374-1383. PubMed ID: 27617574
[TBL] [Abstract][Full Text] [Related]
8. An ARF-independent c-MYC-activated tumor suppression pathway mediated by ribosomal protein-Mdm2 Interaction.
Macias E; Jin A; Deisenroth C; Bhat K; Mao H; Lindström MS; Zhang Y
Cancer Cell; 2010 Sep; 18(3):231-43. PubMed ID: 20832751
[TBL] [Abstract][Full Text] [Related]
9. Perturbation of ribosome biogenesis drives cells into senescence through 5S RNP-mediated p53 activation.
Nishimura K; Kumazawa T; Kuroda T; Katagiri N; Tsuchiya M; Goto N; Furumai R; Murayama A; Yanagisawa J; Kimura K
Cell Rep; 2015 Mar; 10(8):1310-23. PubMed ID: 25732822
[TBL] [Abstract][Full Text] [Related]
10. Loss of tumor suppressor RPL5/RPL11 does not induce cell cycle arrest but impedes proliferation due to reduced ribosome content and translation capacity.
Teng T; Mercer CA; Hexley P; Thomas G; Fumagalli S
Mol Cell Biol; 2013 Dec; 33(23):4660-71. PubMed ID: 24061479
[TBL] [Abstract][Full Text] [Related]
11. Aberrant ribosome biogenesis activates c-Myc and ASK1 pathways resulting in p53-dependent G1 arrest.
Kim HD; Kim TS; Kim J
Oncogene; 2011 Jul; 30(30):3317-27. PubMed ID: 21383696
[TBL] [Abstract][Full Text] [Related]
12. The roles of RRP15 in nucleolar formation, ribosome biogenesis and checkpoint control in human cells.
Dong Z; Zhu C; Zhan Q; Jiang W
Oncotarget; 2017 Feb; 8(8):13240-13252. PubMed ID: 28099941
[TBL] [Abstract][Full Text] [Related]
13. Importin 7 and exportin 1 link c-Myc and p53 to regulation of ribosomal biogenesis.
Golomb L; Bublik DR; Wilder S; Nevo R; Kiss V; Grabusic K; Volarevic S; Oren M
Mol Cell; 2012 Jan; 45(2):222-32. PubMed ID: 22284678
[TBL] [Abstract][Full Text] [Related]
14. Impaired ribosome biogenesis checkpoint activation induces p53-dependent MCL-1 degradation and MYC-driven lymphoma death.
Domostegui A; Peddigari S; Mercer CA; Iannizzotto F; Rodriguez ML; Garcia-Cajide M; Amador V; Diepstraten ST; Kelly GL; Salazar R; Kozma SC; Kusnadi EP; Kang J; Gentilella A; Pearson RB; Thomas G; Pelletier J
Blood; 2021 Jun; 137(24):3351-3364. PubMed ID: 33512431
[TBL] [Abstract][Full Text] [Related]
15. Ribosomal protein L4 is a novel regulator of the MDM2-p53 loop.
He X; Li Y; Dai MS; Sun XX
Oncotarget; 2016 Mar; 7(13):16217-26. PubMed ID: 26908445
[TBL] [Abstract][Full Text] [Related]
16. The 5S RNP couples p53 homeostasis to ribosome biogenesis and nucleolar stress.
Sloan KE; Bohnsack MT; Watkins NJ
Cell Rep; 2013 Oct; 5(1):237-47. PubMed ID: 24120868
[TBL] [Abstract][Full Text] [Related]
17. Interleukin 6 downregulates p53 expression and activity by stimulating ribosome biogenesis: a new pathway connecting inflammation to cancer.
Brighenti E; Calabrese C; Liguori G; Giannone FA; Trerè D; Montanaro L; Derenzini M
Oncogene; 2014 Aug; 33(35):4396-406. PubMed ID: 24531714
[TBL] [Abstract][Full Text] [Related]
18. Oncogenic c-Myc-induced lymphomagenesis is inhibited non-redundantly by the p19Arf-Mdm2-p53 and RP-Mdm2-p53 pathways.
Meng X; Carlson NR; Dong J; Zhang Y
Oncogene; 2015 Nov; 34(46):5709-17. PubMed ID: 25823025
[TBL] [Abstract][Full Text] [Related]
19. Structure of nascent 5S RNPs at the crossroad between ribosome assembly and MDM2-p53 pathways.
Castillo Duque de Estrada NM; Thoms M; Flemming D; Hammaren HM; Buschauer R; Ameismeier M; Baßler J; Beck M; Beckmann R; Hurt E
Nat Struct Mol Biol; 2023 Aug; 30(8):1119-1131. PubMed ID: 37291423
[TBL] [Abstract][Full Text] [Related]
20. Acrolein preferentially damages nucleolus eliciting ribosomal stress and apoptosis in human cancer cells.
Wang HT; Chen TY; Weng CW; Yang CH; Tang MS
Oncotarget; 2016 Dec; 7(49):80450-80464. PubMed ID: 27741518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]